NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.

The Genedata Biologics platform will support multiple groups within GSK including teams working on lead identification and screening, protein optimization and engineering, and protein production. GSK will use the system to record, manage, share, and process data from its antibody discovery platforms, including its phage and yeast display, hybridoma, and other technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.